Search
+
    SEARCHED FOR:

    SWIGGY IPO ALLOTMENT

    Transrail Lighting IPO oversubscribed by retail investors. Check key dates, price band, GMP and review

    The IPO includes a fresh equity issue of Rs 400 crore and an offer-for-sale (OFS) of 1.01 crore shares by promoter Ajanma Holdings. At the upper price band, the OFS is valued at Rs 439 crore, bringing the total issue size to approximately Rs 839 crore and valuing the company at a market capitalization of about Rs 5,800 crore.

    Nomura picks stake worth Rs 325 crore in Vishal Mega Mart via bulk deal

    Nomura India Investment Fund bought a 3 crore stake in Vishal Mega Mart post-listing, which saw a 43.5% gain. Experts suggest conservative investors book profits, while long-term investors hold.

    Morgan Stanley, others pick stake in Concord Enviro ahead of Rs 500 cr IPO

    Morgan Stanley Asia (Singapore) PTE-ODI, along with Societe Generale, emerged as a prominent foreign institutional investor in the anchor bidding round of Concord Enviro Systems' IPO, which raised Rs 150.09 crore from anchor investors prior to its public offering.

    Vishal Mega Mart IPO: GMP, price band, key dates among top 10 things to know about the Rs 8,000 crore issue

    Vishal Mega Mart's IPO, valued at Rs 8,000 crore, is set to be one of the largest of the year, following major offerings from Hyundai Motor India, Swiggy, and NTPC Green Energy. Market analysts report a current GMP of Rs 19, suggesting a 24% premium over the issue price.

    Ganesh Infraworld IPO Day 3: GMP, Price Band, Subscription and Key Dates

    Ganesh Infraworld's SME IPO achieves a substantial subscription of 369.7 times, aiming to raise Rs 98.6 crore with a fresh equity sale of 1.18 crore shares. The funds are allocated for long-term working capital and corporate purposes. The shares are priced between Rs 78-83, with a GMP of Rs 73, indicating an 88% upside potential.

    Suraksha Diagnostic IPO subscribed 1.27 times on final day of bidding. Check GMP, Price Band, Key Dates and Review

    Suraksha Diagnostic's IPO was fully subscribed on the final day despite initial lukewarm interest. This was due to its offer-for-sale structure, meaning proceeds will not go to the company but to selling shareholders. Most analysts recommended avoiding the IPO due to its high valuation and competitive sector. The listing is set for December 6.

    The Economic Times
    BACK TO TOP
      翻译: